GoodRx Holdings
GDRX
142 hedge funds and large institutions have $949M invested in GoodRx Holdings in 2023 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 51 reducing their positions, and 30 closing their positions.
22% more capital invested
Capital invested by funds: $776M → $949M (+$174M)
10% more call options, than puts
Call options by funds: $4.1M | Put options by funds: $3.72M
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
8% less funds holding
Funds holding: 155 → 142 (-13)
10.44% less ownership
Funds ownership: 163.8% → 153.36% (-10%)
20% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 51
33% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$33.1M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$24.6M |
| 3 |
LCM
Lakewood Capital Management
New York
|
+$4.25M |
| 4 |
Morgan Stanley
New York
|
+$2.94M |
| 5 |
RRCP
Rip Road Capital Partners
Boston,
Massachusetts
|
+$2.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$8.98M |
| 2 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$8.87M |
| 3 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
-$4.57M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.88M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$3.62M |
GDRX Hedge Fund Activity: Q4 2023 in Review
142 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q4 2023, worth a combined $949M — up 22% from $776M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of GDRX and 20 opened new positions — a net loss of 10 holders — while 51 trimmed existing stakes and 41 added.
The largest buyer was Rubric Capital Management (New York), opening a new position worth an estimated $33.1M. The largest seller was OrbiMed, exiting entirely with an estimated $8.98M sold.
- 142 institutional investors held GoodRx Holdings (GDRX) as of Q4 2023, down from 155 in Q3 2023.
- Funds reported $949M of GoodRx Holdings stock for Q4 2023, up 22% quarter-over-quarter.
- 20 funds opened new GoodRx Holdings positions in Q4 2023 and 30 closed out, a net change of -10 holders.
- The largest GoodRx Holdings buyer in Q4 2023 was Rubric Capital Management (New York), an estimated $33.1M added.
- The largest GoodRx Holdings seller in Q4 2023 was OrbiMed, an estimated $8.98M sold.
Based on aggregated 13F filings for Q4 2023.